|
1
|
Liu Y, Zhu H, Mo L, Xu R, Li X, Li T, Zhao
L, Ren Y, Ou R and Xu Y: Flt3L and GM-CSF enhance anti-tumor effect
of HPV16/18 vaccine via increasing immune response. Am J Transl
Res. 12:6027–6042. 2020.PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Forman D, de Martel C, Lacey CJ,
Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J,
Bray F, Plummer M and Franceschi S: Global burden of human
papillomavirus and related diseases. Vaccine. 5:F12–F23.
2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Nesset AL and Bader DM: Hole is a novel
gene product expressed in the developing heart and brain. Mech Dev.
117:347–350. 2002.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhou J, Li Y, Liang P, Yuan W, Ye X, Zhu
C, Cheng Y, Wang Y, Li G, Wu X and Liu M: A novel six-transmembrane
protein hhole functions as a suppressor in MAPK signaling pathways.
Biochem Biophys Res Commun. 333:344–352. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Xu W, Wang Y, Zhou J, Zhu X, Zhang S, Yuan
W, Liu X, Shi Y, Cao L, Zeng Q, et al: Cardiac specific
overexpression of hHole attenuates isoproterenol-induced
hypertrophic remodeling through inhibition of extracellular
signal-regulated kinases (ERKs) signalling. Curr Mol Med.
16:515–523. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu
JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis
of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6(pl1)2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Vasaikar SV, Straub P, Wang J and Zhang B:
LinkedOmics: Analyzing multi-omics data within and across 32 cancer
types. Nucleic Acids Res. 46:D956–D963. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Nagy Á, Munkácsy G and Győrffy B:
Pancancer survival analysis of cancer hallmark genes. Sci Rep.
11(6047)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chandrashekar DS, Bashel B, Balasubramanya
SA, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BV and Varambally
S: UALCAN: A portal for facilitating tumor subgroup gene expression
and survival analyses. Neoplasia. 19:649–658. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gu Z, Eils R and Schlesner M: Complex
heatmaps reveal patterns and correlations in multidimensional
genomic data. Bioinformatics. 32:2847–2849. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gene Ontology Consortium: Going forward.
Nucleic Acids Res. 43:D1049–D1056. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Esteller M: CpG island hypermethylation
and tumor suppressor genes: A booming present, a brighter future.
Oncogene. 21:5427–5440. 2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ushijima T and Asada K: Aberrant DNA
methylation in contrast with mutations. Cancer Sci. 101:300–305.
2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hoxhaj G and Manning BD: The PI3K-AKT
network at the interface of oncogenic signalling and cancer
metabolism. Nat Rev Cancer. 20:74–88. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kato J, Matsushime H, Hiebert SW, Ewen ME
and Sherr CJ: Direct binding of cyclin D to the retinoblastoma gene
product (pRb) and pRb phosphorylation by the cyclin D-dependent
kinase CDK4. Genes Dev. 7:331–342. 1993.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Knudsen ES and Knudsen KE: Tailoring to
RB: Tumour suppressor status and therapeutic response. Nat Rev
Cancer. 8:714–724. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Pérez-Luna M, Aguasca M, Perearnau A,
Serratosa J, Martínez-Balbas M, Pujol MJ and Bachs O: PCAF
regulates the stability of the transcriptional regulator and
cyclin-dependent kinase inhibitor p27 Kip1. Nucleic Acids Res.
40:6520–6533. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Perearnau A, Orlando S, Islam A,
Gallastegui E, Martínez J, Jordan A, Bigas A, Aligué R, Pujol MJ
and Bachs O: p27Kip1, PCAF and PAX5 cooperate in the
transcriptional regulation of specific target genes. Nucleic Acids
Res. 45:5086–5099. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Roilo M, Kullmann MK and Hengst L:
Cold-inducible RNA-binding protein (CIRP) induces translation of
the cell-cycle inhibitor p27Kip1. Nucleic Acids Res. 46:3198–3210.
2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu L, Michowski W, Inuzuka H, Shimizu K,
Nihira NT, Chick JM, Li N, Geng Y, Meng AY, Ordureau A, et al: G1
cyclins link proliferation, pluripotency and differentiation of
embryonic stem cells. Nat Cell Biol. 19:177–188. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hydbring P, Wang Y, Fassl A, Li X, Matia
V, Otto T, Choi YJ, Sweeney KE, Suski JM, Yin H, et al:
Cell-cycle-targeting micrornas as therapeutic tools against
refractory cancers. Cancer Cell. 31:576–590.e8. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wu J, Dang Y, Su W, Liu C, Ma H, Shan Y,
Pei Y, Wan B, Guo J and Yu L: Molecular cloning and
characterization of rat LC3A and LC3B-two novel markers of
autophagosome. Biochem Biophys Res Commun. 339:437–442.
2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bruner HC and Derksen PWB: Loss of
e-cadherin-dependent cell-cell adhesion and the development and
progression of cancer. Cold Spring Harb Perspect Biol.
10(a029330)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang D, Yang T, Liu J, Liu Y, Xing N, He
J, Yang J and Ai Y: Propofol inhibits the migration and invasion of
glioma cells by blocking the PI3K/AKT pathway through miR-206/ROCK1
axis. Onco Targets Ther. 13:361–370. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sheng XY, Wang CH, Wang CF and Xu HY:
Long-chain non-coding SOX21-AS1 promotes proliferation and
migration of breast cancer cells through the PI3K/AKT signaling
pathway. Cancer Manag Res. 12:11005–11014. 2020.PubMed/NCBI View Article : Google Scholar
|
